EMBL Hamburg Logo
Travel and Contact  Staff Only  Site Map  Help?   
EMBL HamburgEuropean Molecular Biology Laboratory
EMBLEMBL GrenobleEMBL HamburgEMBL HeidelbergEMBL-EBI HinxtonEMBL Monterotondo
EMBL Hamburg > Courses and Conferences
 
Invitation
 
Poster
 
Speakers
 
Sponsors
 
Organisers
 
Programme
 
Pictures
 
   16 September
 
   15 September
 
   PDB Exhibition
 
Joel Sussman -
Studies during the last decade have identified a family of neural cell adhesion proteins, which are single-pass transmembrane proteins, with substantial sequence similarity to cholinesterases (ChEs). The regions of sequence similarity correspond to only part of their complete sequences, thus establishing the ChE domain as a modular domain incorporated into different proteins, i.e. cholinesterase-like adhesion molecules (CLAMs)(1-4). CLAMs, however, devoid of catalytic activity, since they lack residues crucial for catalysis. They appear to play a key role in the earliest stages of the development of the CNS and mutations, in the ChE domain of one of them, i.e. neuroligin, has been associated with autism(5-7).

The cytoplasmic domains of CLAMs bear no sequence homology to any known protein, and physicochemical studies show that they are 'intrinsically disordered' (8,9) when expressed in E. coli(3). It has been estimated that a large percentage of cellular proteins exist in this disordered state(8); e.g., in eukaryotic cells, the estimated range is 36-63%. Using an extension of the algorithm described by Uversky and coworkers(9), we have developed a web-based tool, FoldIndex © (see http://bioportal.weizmann.ac.il/fldbin/findex), which has proven useful in predicting regions of a new protein sequence that are likely to be disordered. We have applied FoldIndex © to examine the CLAMs family as well as cholinesterase molecules. These 'in silico' studies will be compared with our recent solution studies on CLAMs and their adhesion partners.

References:
  1. Botti, S. A., et al., Protein Eng. 11, 415-420 (1998).
  2. Felder, C. E., et al., J. Molec. Graphics & Modelling 15, 318-327 (1997).
  3. Zeev-Ben-Mordehai, T., et al., Proteins 53, 758-767 (2003).
  4. Soreq, H., Seidman, S., Nature Reviews of Neuroscience 2, 294-302 (2001).
  5. Laumonnier, F., et al., Am. J. Hum. Genet. 74, 552-557 (2004).
  6. Jamain, S., et al., Nature Genet. 34, 27-29 (2003).
  7. Comoletti, D., et al., J. Neurosci. 24, 4889-4893 (2004).
  8. Dunker, A. K., et al., Biochemistry 41, 6573-6582 (2002).
  9. Uversky, V. N., Gillespie, J. R., Fink, A. L., Proteins 41, 415-427 (2000).


This work was supported by The Israel Ministry of Science and Technology (MOST) infrastructure grant for the Israel Structural Proteomics Center; by The European Commission Fifth Framework 'Quality of Life and Management of Living Resources' 'SPINE' (Structural Proteomics in Europe) Project; Grant number: QLG2-CT-2002-00988; and by a grant from the Divadol Foundation (Rehovot, Israel).